Literature DB >> 5444064

Norepinephrine turnover and metabolism in rat brain after long-term administration of imipramine.

J J Schildkraut, A Winokur, C W Applegate.   

Abstract

The rate of disappearance of intracisternally administered tritiated norepinephrine from rat brain is decreased after a single dose of the tricyclic antidepressant imipramine. During long-term administration of imipramine, however, the rate of disappearance of tritiated norepinephrine from brain gradually increases, and there is a concurrent decrease in the content of endogenous norepinephrine in brain. These findings may help to explain why antidepressant effects are observed clinically only after long-termn treatment with imipramine.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5444064     DOI: 10.1126/science.168.3933.867

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  12 in total

1.  Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women.

Authors:  C M Banki
Journal:  Eur J Clin Pharmacol       Date:  1977-04-20       Impact factor: 2.953

2.  Effect of iprindole on norepinephrine turnover and transport.

Authors:  B N Rosloff; J M Davis
Journal:  Psychopharmacologia       Date:  1974

3.  Thyrotropin releasing hormone: neurochemical evidence for the potentiation of imipramine effects on the metabolism and uptake of brain catecholamines.

Authors:  R B Rastogi; R L Singhal; Y D Lapierre
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

4.  Effect of caroxazone, a new antidepressant drug, on monoamine oxidases in healthy volunteers.

Authors:  A Moretti; C Caccia; A Martini; L Bonollo; A Amico; R Sega; V Nicolella; F B Nicolis
Journal:  Br J Clin Pharmacol       Date:  1981-05       Impact factor: 4.335

5.  Chronic treatment with desipramine caused a sustained decrease of 3,4-dihydroxyphenylglycol-sulphate and total 3-methoxy-4-hydroxyphenylglycol in the rat brain.

Authors:  M Nielsen; C Braestrup
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-10       Impact factor: 3.000

6.  Toward a biochemical classification of depressive disorders. III: Pretreatment urinary MHPG levels as predictors of response to treatment with maprotiline.

Authors:  A F Schatzberg; A H Rosenbaum; P J Orsulak; W A Rohde; T Maruta; E R Kruger; J O Cole; J J Schildkraut
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

7.  Behavioural changes during withdrawal from desmethylimipramine (DMI). I. Interactions with amphetamine.

Authors:  P Willner; T Montgomery
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

8.  Enhanced norepinephrine output during long-term desipramine treatment: a possible role for the extraneuronal monoamine transporter (SLC22A3).

Authors:  John J Mooney; Jacqueline A Samson; John Hennen; Kathleen Pappalardo; Nancy McHale; Jonathan Alpert; Martha Koutsos; Joseph J Schildkraut
Journal:  J Psychiatr Res       Date:  2007-08-28       Impact factor: 4.791

9.  Decrease in brain NE turnover after chronic DMI treatment; no effect with iprindole.

Authors:  B N Rosloff; J M Daivis
Journal:  Psychopharmacology (Berl)       Date:  1978-04-11       Impact factor: 4.530

10.  Metabolism of 5-hydroxytryptamine and levels of tricyclic antidepressant drugs in rat brain after acute and chronic treatment.

Authors:  M van Wijk; J J Meisch; J Korf
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.